BriaCell Therapeutics Corp. (BCT)
NEO
5.04
+0.0050 (+0.10%)
Real-time Data
01:30 PM
Day's Range
5.025.16
52 wk Range
3.7319.12
Overview - BCT - BriaCell Therapeutics Corp.
Key Statistics
Trading
Volume
1.30K
Average Volume
380
Peers - BCT - BriaCell Therapeutics Corp.
Peer Comparison
Compared with companies in Biotechnology listed on NEO.
- BCTNEOBriaCell Therapeutics Corp.-138.93%52-week change—P/E (Trailing)—Profit Margin
- BMNDNEOBiomind Labs Inc.+49.27%52-week change-69.00P/E (Trailing)‪0.00%‬Profit Margin
- BOLTNEO26 Metals Inc.+97.50%52-week change—P/E (Trailing)—Profit Margin
- BETRNEOBetterLife Pharma Inc.+73.33%52-week change—P/E (Trailing)—Profit Margin
- APMNEOAndean Precious Metals Corp.+33.77%52-week change—P/E (Trailing)—Profit Margin
- BLABNEOBritannia Life Sciences Inc.-26.67%52-week change—P/E (Trailing)—Profit Margin
- ARCHNEOArch Biopartners Inc.-66.67%52-week change—P/E (Trailing)—Profit Margin
Profile Summary - BCT - BriaCell Therapeutics Corp.
About
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company specializing in developing novel immunotherapies to transform cancer care. The company focuses on cell-based cancer immunotherapies designed to harness and direct the immune system against tumors, with initial emphasis on metastatic breast cancer…
SectorHealthcare
IndustryBiotechnology
Employees16
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
